Hamidreza Saebfar

704 total citations
10 papers, 421 citations indexed

About

Hamidreza Saebfar is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Hamidreza Saebfar has authored 10 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Biomaterials. Recurrent topics in Hamidreza Saebfar's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Hamidreza Saebfar is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Hamidreza Saebfar collaborates with scholars based in Iran, United States and Türkiye. Hamidreza Saebfar's co-authors include Maliheh Entezari, Mehrdad Hashemi, Shokooh Salimimoghadam, Afshin Taheriazam, Amirabbas Kakavand, Sima Orouei, Saeed Samarghandian, Kiavash Hushmandi, Elahe Sadat Hejazi and Shamin Rezaei and has published in prestigious journals such as Life Sciences, Journal of Cellular Physiology and Environmental Research.

In The Last Decade

Hamidreza Saebfar

10 papers receiving 419 citations

Peers

Hamidreza Saebfar

MB

CR

ONCOL

PRM

BE

Haijun Lu China

Zixue Xuan China

Vahideh Zarrin Iran

Sung-Won Shin South Korea

Kanqiu Jiang China

Hongfang Sun China

Yuwen Xie China

Hengxing Chen China

Qianwei Ye China

Diana Farhat France

Haijun Lu China

Hamidreza Saebfar

216 ×0.8

MB

126 ×0.8

CR

92 ×0.9

ONCOL

57 ×0.9

PRM

34 ×0.8

BE

Citations per year, relative to Hamidreza Saebfar Hamidreza Saebfar (= 1×) peers Haijun Lu

Countries citing papers authored by Hamidreza Saebfar

Since Specialization

Citations

This map shows the geographic impact of Hamidreza Saebfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamidreza Saebfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamidreza Saebfar more than expected).

Fields of papers citing papers by Hamidreza Saebfar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamidreza Saebfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamidreza Saebfar. The network helps show where Hamidreza Saebfar may publish in the future.

Co-authorship network of co-authors of Hamidreza Saebfar

This figure shows the co-authorship network connecting the top 25 collaborators of Hamidreza Saebfar. A scholar is included among the top collaborators of Hamidreza Saebfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamidreza Saebfar. Hamidreza Saebfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Entezari, Maliheh, Ali Jebali, Ramin Khorrami, et al.. (2023). Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers. Environmental Research. 225. 115673–115673. 21 indexed citations

2.

Hashemi, Mehrdad, Mahshid Deldar Abad Paskeh, Zeinab Khazaei Koohpar, et al.. (2023). Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery. Biomedicine & Pharmacotherapy. 169. 115927–115927. 11 indexed citations

3.

Sadrkhanloo, Mehrdokht, Maliheh Entezari, Sima Orouei, et al.. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research. 182. 106311–106311. 114 indexed citations

4.

Hashemi, Mehrdad, Sima Orouei, Amin Ghorbani, et al.. (2022). EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomedicine & Pharmacotherapy. 155. 113774–113774. 103 indexed citations

5.

Hashemi, Mehrdad, Sepideh Mirzaei, Mohammad Arad Zandieh, et al.. (2022). Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Progress in Biophysics and Molecular Biology. 177. 207–228. 8 indexed citations

6.

Hashemi, Mehrdad, Afshin Taheriazam, Amirabbas Kakavand, et al.. (2022). Targeting PI3K/Akt signaling in prostate cancer therapy. Journal of Cell Communication and Signaling. 17(3). 423–443. 58 indexed citations

7.

Paskeh, Mahshid Deldar Abad, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.. (2022). Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sciences. 298. 120463–120463. 44 indexed citations

8.

Hashemi, Mehrdad, Sima Orouei, Amin Ghorbani, et al.. (2022). Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions. Pharmacological Research. 185. 106475–106475. 22 indexed citations

9.

Mahabady, Mahmood Khaksary, Sepideh Mirzaei, Hamidreza Saebfar, et al.. (2022). Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. Journal of Cellular Physiology. 237(5). 2309–2344. 18 indexed citations

10.

Mirzaei, Sepideh, Hamidreza Saebfar, Mohammad Gholami, et al.. (2021). MicroRNAs regulating SOX2 in cancer progression and therapy response. Expert Reviews in Molecular Medicine. 23. e13–e13. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact